Satsuma Pharmaceuticals Berita Eulerpool

Satsuma Pharmaceuticals Eulerpool News

Satsuma Pharmaceuticals Berita Saham

Satsuma Pharmaceuticals diawasi oleh banyak jurnalis dan investor di seluruh dunia. Berita terkini Satsuma Pharmaceuticals kami rangkum di sini.

• 17 Juli ·

  SeekingAlpha
  Leaven Partners Second Quarter 2023 Letter To Partners
• 9 Juni ·

  Benzinga
  Satsuma Pharmaceuticals And 2 Other Penny Stocks Insiders Are Aggressively Buying
• 18 Mei ·

  Yahoo
  Satsuma Pharmaceuticals Announces FDA Acceptance of 505(b)(2) NDA for STS101, a Novel and Investigational Dihydroergotamine (DHE) Nasal Powder Product for the Acute Treatment of Migraine
• 18 Mei ·

  Seeking Alpha
  Satsuma migraine therapy accepted for FDA review
• 18 Mei ·

  Thefly.com
  Satsuma: FDA accepts NDA for STS101 for acute migraine treatment
• 15 Mei ·

  TipRanks
  JonesTrading Sticks to Its Hold Rating for Satsuma Pharmaceuticals (STSA)
• 21 April ·

  Yahoo
  Satsuma Pharmaceuticals Announces Three Abstracts Accepted at The 75th American Academy of Neurology Annual Meeting
• 21 April ·

  Thefly.com
  Satsuma Pharmaceuticals announces three abstracts accepted at AAN meeting
• 19 April ·

  Thefly.com
  Biotech Alert: Searches spiking for these stocks today
• 19 April ·

  Fintel
  HC Wainwright & Co. Downgrades Satsuma Pharmaceuticals (STSA)